Electrome is the bioelectric medicine platform. Providers, retailers, affiliates, investors, researchers, government partners, licensors, health systems, clinical trial networks, and academic teams all build on the same FDA-cleared bioelectric foundation.
Electrome operates as a hub. Pick the role that fits and we will scroll you to the program that matters to you, with every other program still visible below.
Partnership opportunities, not a directory of existing partners. Select a node to explore the matching program below.
Integrate FDA-cleared PSWT into postoperative recovery and musculoskeletal pain pathways with clinician facing tooling.
Stock FDA-cleared bioelectric pain therapy, available over-the-counter (OTC), with tiered wholesale pricing and strong unit economics.
Promote drug-free pain relief from FDA-cleared devices and earn recurring commission with full creative support and approved claims.
Vertical bioelectric platform anchored by FDA-cleared revenue product, an active pipeline, and an institutional biotech IR cadence.
Partner on investigator initiated trials, mechanism of action studies, and pipeline indication research.
Engage with federal partners (NIH, BARDA, ARPA-H, VA, DoD) on non-opioid pain, recovery, and bioelectric medicine programs.
License or co manufacture PSWT modules and signal IP for OEM, white label, and integration into adjacent therapeutic platforms.
System wide deployment of bioelectric care pathways with formulary, supply, and analytics integration for IDNs, ACOs, and payers.
Decentralized trials, real world evidence, and wearables enabled studies that capture continuous adherence and outcome telemetry.
University research groups, translational science teams, and academic medical centers exploring bioelectric mechanisms and indications.
Every Electrome program is anchored by FDA 510(k) cleared PSWT devices with documented quality system rigor.
Specialized agents support research and partner workflows while people inspect outputs, approve actions, and retain decision authority.
Drug-free, non thermal, wearable bioelectric therapy designed to reduce reliance on opioids and other pain drugs.
Devices, portals, and AI workflows ship as modules so partners can adopt only what they need and scale at their pace.
Decades of peer-reviewed PSWT research plus an active pipeline of investigator initiated and registry studies.
Multi channel distribution across DTC, retail, pharmacy, provider, and enterprise with shared partner infrastructure.
Adherence and outcome telemetry across portals, ready for partner reporting, payer pilots, and study designs.
Non thermal, drug-free, noncontact wearable PSWT at 27.12 MHz with 720 hour continuous therapy. No electrodes. Wear directly on the skin with the included tape or a wrap, or over thin clothing; avoid thick fabric.
Specialized agents support evidence and operational workflows while human reviewers approve actions and retain decision authority.
Device, software, AI, and partner facing infrastructure as modules that compose into clinical, retail, or research stacks.
Bioelectric signal IP and platform APIs designed for the next era of indications beyond chronic pain.
Restrained indicators of the foundation partners build on. No metrics overload.
Anchored by 510(k) cleared PSWT devices in active clinical use.
Bioelectric and PSWT research lineage informs every program.
Across PEMF and adjacent bioelectric mechanisms.
Veteran health context and deployment relationships.
ActiPatch was evaluated in NASA testing of pain and recovery technologies.
DTC, retail, pharmacy, provider, enterprise, and international.
Veteran care research collaborations on chronic pain.
Lyme disease and bioelectric inflammation research.
Manufacturer of FDA-cleared ActiPatch and RecoveryRx PSWT devices.
ActiPatch was evaluated in NASA testing of pain and recovery technologies.
Single arm and multi site pilots run with clinical and academic partners.
Mechanism of action, registry, and translational science programs in scope.
Indications and partner surfaces we are actively scoping.
Bioelectric signaling for nervous system targeted recovery and pain.
Inflammation and immune modulation pathways under exploration.
Adjuncts to oncology recovery and supportive care, scoped under research.
Bioelectric inflammation research informing infection adjacent indications.
Menstrual pain, postpartum recovery, and pelvic pain research opportunities.
Surgical, athletic, and chronic recovery surfaces across populations.
AI guided protocol design and multi modal outcome modeling.
Resources are released selectively based on the partnership type. Submit an inquiry and the right pack will be sent to you.
Logos, brand assets, photography, and approved claims for partner use.
Platform thesis, mechanism, and bioelectric medicine context.
Peer-reviewed studies and meta analyses for PEMF.
Coding, coverage notes, and payer engagement context.
Provider, retailer, and affiliate onboarding packets.
Clinical pathway, retail merchandising, and pilot rollout playbooks.
Round overview, pipeline, and data room access for institutional investors.
510(k) clearances, quality system context, and labeling references.
Three quick steps. Your inquiry routes to the right team and reaches a human within two business days.
Technical and licensing inquiries route to Erik A. Nilsen, PhD. Investor inquiries route to the executive team.
Bioelectric medicine is moving from research into clinical practice, retail, and policy. The partners we work with help shape what comes next.
